Obese patients benefit from minimally invasive colorectal cancer surgery

Courtney J. Balentine, Christy Marshall, Celia Robinson, Jonathan Wilks, Daniel Anaya, Daniel Albo, David H. Berger

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Minimally invasive surgery (MIS) for colorectal cancer offers improved short-term outcomes compared with open surgery. However, there is concern that MIS is more difficult in obese patients and may be associated with worse oncologic outcomes while failing to preserve short-term benefits. We hypothesized that obese patients undergoing surgery for colorectal cancer (CRC) would benefit from MIS. Methods: Retrospective database review. Results: Database review identified 155 obese patients undergoing resections for CRC from 2002-2009. Open cases accounted for 73% (N = 113) and MIS for 27% (N = 42). Conversion from MIS to open surgery occurred in 26% of cases. Obese patients had a nonsignificantly decreased rate of wound infection after MIS (21%) versus open surgery (28%, P < 0.645), while the incidence of other complications did not differ by surgical approach. The MIS cohort demonstrated faster return of bowel function and returned home a median of 2 days faster group than in the open surgery group (P < 0.003). From an oncologic standpoint, MIS was at least equivalent to open surgery as median number of lymph nodes extracted (20 versus 15, P < 0.073) and proportion of margin negative resections (97% versus 98%, P < 0.654) did not significantly differ between the two groups. Conclusions: Minimally invasive surgery for CRC is safe and effective in obese patients since bowel function recovers rapidly, and hospital stay is significantly reduced while the quality of oncologic care is maintained.

Original languageEnglish (US)
Pages (from-to)29-34
Number of pages6
JournalJournal of Surgical Research
Volume163
Issue number1
DOIs
StatePublished - Sep 1 2010
Externally publishedYes

Fingerprint

Colorectal Surgery
Minimally Invasive Surgical Procedures
Colorectal Neoplasms
Databases
Quality of Health Care
Wound Infection
Length of Stay
Lymph Nodes
Incidence

Keywords

  • colorectal cancer
  • minimally invasive surgery
  • obesity

ASJC Scopus subject areas

  • Surgery

Cite this

Balentine, C. J., Marshall, C., Robinson, C., Wilks, J., Anaya, D., Albo, D., & Berger, D. H. (2010). Obese patients benefit from minimally invasive colorectal cancer surgery. Journal of Surgical Research, 163(1), 29-34. https://doi.org/10.1016/j.jss.2010.03.063

Obese patients benefit from minimally invasive colorectal cancer surgery. / Balentine, Courtney J.; Marshall, Christy; Robinson, Celia; Wilks, Jonathan; Anaya, Daniel; Albo, Daniel; Berger, David H.

In: Journal of Surgical Research, Vol. 163, No. 1, 01.09.2010, p. 29-34.

Research output: Contribution to journalArticle

Balentine, CJ, Marshall, C, Robinson, C, Wilks, J, Anaya, D, Albo, D & Berger, DH 2010, 'Obese patients benefit from minimally invasive colorectal cancer surgery', Journal of Surgical Research, vol. 163, no. 1, pp. 29-34. https://doi.org/10.1016/j.jss.2010.03.063
Balentine, Courtney J. ; Marshall, Christy ; Robinson, Celia ; Wilks, Jonathan ; Anaya, Daniel ; Albo, Daniel ; Berger, David H. / Obese patients benefit from minimally invasive colorectal cancer surgery. In: Journal of Surgical Research. 2010 ; Vol. 163, No. 1. pp. 29-34.
@article{f76c997742af473cabe45e3c468ff4eb,
title = "Obese patients benefit from minimally invasive colorectal cancer surgery",
abstract = "Background: Minimally invasive surgery (MIS) for colorectal cancer offers improved short-term outcomes compared with open surgery. However, there is concern that MIS is more difficult in obese patients and may be associated with worse oncologic outcomes while failing to preserve short-term benefits. We hypothesized that obese patients undergoing surgery for colorectal cancer (CRC) would benefit from MIS. Methods: Retrospective database review. Results: Database review identified 155 obese patients undergoing resections for CRC from 2002-2009. Open cases accounted for 73{\%} (N = 113) and MIS for 27{\%} (N = 42). Conversion from MIS to open surgery occurred in 26{\%} of cases. Obese patients had a nonsignificantly decreased rate of wound infection after MIS (21{\%}) versus open surgery (28{\%}, P < 0.645), while the incidence of other complications did not differ by surgical approach. The MIS cohort demonstrated faster return of bowel function and returned home a median of 2 days faster group than in the open surgery group (P < 0.003). From an oncologic standpoint, MIS was at least equivalent to open surgery as median number of lymph nodes extracted (20 versus 15, P < 0.073) and proportion of margin negative resections (97{\%} versus 98{\%}, P < 0.654) did not significantly differ between the two groups. Conclusions: Minimally invasive surgery for CRC is safe and effective in obese patients since bowel function recovers rapidly, and hospital stay is significantly reduced while the quality of oncologic care is maintained.",
keywords = "colorectal cancer, minimally invasive surgery, obesity",
author = "Balentine, {Courtney J.} and Christy Marshall and Celia Robinson and Jonathan Wilks and Daniel Anaya and Daniel Albo and Berger, {David H.}",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.jss.2010.03.063",
language = "English (US)",
volume = "163",
pages = "29--34",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Obese patients benefit from minimally invasive colorectal cancer surgery

AU - Balentine, Courtney J.

AU - Marshall, Christy

AU - Robinson, Celia

AU - Wilks, Jonathan

AU - Anaya, Daniel

AU - Albo, Daniel

AU - Berger, David H.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Background: Minimally invasive surgery (MIS) for colorectal cancer offers improved short-term outcomes compared with open surgery. However, there is concern that MIS is more difficult in obese patients and may be associated with worse oncologic outcomes while failing to preserve short-term benefits. We hypothesized that obese patients undergoing surgery for colorectal cancer (CRC) would benefit from MIS. Methods: Retrospective database review. Results: Database review identified 155 obese patients undergoing resections for CRC from 2002-2009. Open cases accounted for 73% (N = 113) and MIS for 27% (N = 42). Conversion from MIS to open surgery occurred in 26% of cases. Obese patients had a nonsignificantly decreased rate of wound infection after MIS (21%) versus open surgery (28%, P < 0.645), while the incidence of other complications did not differ by surgical approach. The MIS cohort demonstrated faster return of bowel function and returned home a median of 2 days faster group than in the open surgery group (P < 0.003). From an oncologic standpoint, MIS was at least equivalent to open surgery as median number of lymph nodes extracted (20 versus 15, P < 0.073) and proportion of margin negative resections (97% versus 98%, P < 0.654) did not significantly differ between the two groups. Conclusions: Minimally invasive surgery for CRC is safe and effective in obese patients since bowel function recovers rapidly, and hospital stay is significantly reduced while the quality of oncologic care is maintained.

AB - Background: Minimally invasive surgery (MIS) for colorectal cancer offers improved short-term outcomes compared with open surgery. However, there is concern that MIS is more difficult in obese patients and may be associated with worse oncologic outcomes while failing to preserve short-term benefits. We hypothesized that obese patients undergoing surgery for colorectal cancer (CRC) would benefit from MIS. Methods: Retrospective database review. Results: Database review identified 155 obese patients undergoing resections for CRC from 2002-2009. Open cases accounted for 73% (N = 113) and MIS for 27% (N = 42). Conversion from MIS to open surgery occurred in 26% of cases. Obese patients had a nonsignificantly decreased rate of wound infection after MIS (21%) versus open surgery (28%, P < 0.645), while the incidence of other complications did not differ by surgical approach. The MIS cohort demonstrated faster return of bowel function and returned home a median of 2 days faster group than in the open surgery group (P < 0.003). From an oncologic standpoint, MIS was at least equivalent to open surgery as median number of lymph nodes extracted (20 versus 15, P < 0.073) and proportion of margin negative resections (97% versus 98%, P < 0.654) did not significantly differ between the two groups. Conclusions: Minimally invasive surgery for CRC is safe and effective in obese patients since bowel function recovers rapidly, and hospital stay is significantly reduced while the quality of oncologic care is maintained.

KW - colorectal cancer

KW - minimally invasive surgery

KW - obesity

UR - http://www.scopus.com/inward/record.url?scp=77955923913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955923913&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2010.03.063

DO - 10.1016/j.jss.2010.03.063

M3 - Article

C2 - 20538294

AN - SCOPUS:77955923913

VL - 163

SP - 29

EP - 34

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -